NCT02310802View on ClinicalTrials.gov

OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICSI

PHASE2CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2016

Conditions
Infertility
Interventions
DRUG

OBE001 dose 1

OBE001 dispersible tablets for single oral administration

DRUG

OBE001 dose 2

OBE001 dispersible tablets for single oral administration

DRUG

OBE001 dose 3

OBE001 dispersible tablets for single oral administration

DRUG

Placebo

Placebo dispersible tablets for single oral administration

Trial Locations (18)

Unknown

Brussels

Hradev Kralove

Olomouc

Prague

Zlín

Copenhagen

Hvidovre

Bialystok

Katowice

Szczecin

Warsaw

Alicante

Barakaldo

Barcelona

Bilbao

Seville

Vigo

London

Sponsors

Lead Sponsor

ObsEva SA
All Listed Sponsors
lead

ObsEva SA

INDUSTRY

NCT02310802 - OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICSI | Biotech Hunter | Biotech Hunter